Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery
January 15th, 2018
15.1K views
We describe a method of synthesizing biocompatible 10-nm gold nanoparticles, functionalized by coating poly-ethylene glycol onto the surface. These particles can be used in vitro and in vivo for delivering therapeutics to nanoscale cellular and extracellular spaces that are difficult to access with conventional nanoparticle sizes.
Overview
This article describes a method for synthesizing biocompatible 10-nm gold nanoparticles coated with polyethylene glycol. These nanoparticles are designed for therapeutic delivery in challenging cellular environments.
Key Study Components
Area of Science
- Nanotechnology
- Biocompatible materials
- Therapeutic delivery systems
Background
- Gold nanoparticles have unique properties beneficial for biomedical applications.
- Conventional nanoparticles may not effectively target certain cellular spaces.
- Functionalization can enhance the performance of nanoparticles.
- This method aims to improve accessibility to difficult-to-reach areas in vivo.
Purpose of Study
- To synthesize ultra-small gold nanoparticles for enhanced biocompatibility.
- To enable imaging and therapeutic applications in cardiology.
- To provide a customizable platform for further nanoparticle modifications.
Methods Used
- Dilution of THPC and preparation of reaction mixtures.
- Stirring and addition of chloroauric acid to form gold nanoparticles.
- Functionalization with various PEG thiols for enhanced properties.
- Characterization using transmission electron microscopy and dynamic light scattering.
Main Results
- Successful synthesis of 10-nm gold nanoparticles with desired properties.
- Demonstrated biocompatibility through cell viability assays.
- Characterization confirmed the size and functionality of the nanoparticles.
- Potential applications in imaging and therapeutic delivery were highlighted.
Conclusions
- The synthesized gold nanoparticles are suitable for biomedical applications.
- Functionalization enhances their usability in targeted therapies.
- This method provides a foundation for future research in nanoparticle applications.
Frequently Asked Questions
What are the advantages of using gold nanoparticles?
Gold nanoparticles offer unique optical properties, biocompatibility, and the ability to be functionalized for specific applications.
How does the functionalization process work?
Functionalization involves coating the nanoparticles with polymers like PEG to enhance their stability and biocompatibility.
What applications can these nanoparticles be used for?
They can be used for drug delivery, imaging, and studying cellular processes in various biomedical fields.
What methods were used to characterize the nanoparticles?
Characterization was performed using transmission electron microscopy and dynamic light scattering to assess size and morphology.
Are these nanoparticles safe for in vivo use?
Yes, the nanoparticles are designed to be biocompatible, making them suitable for in vivo applications.
What is the significance of the particle size?
The 10-nm size allows for better penetration into cellular environments that larger particles cannot access.
Executive Industry Relevance
This method enables the synthesis of biocompatible, fluorescently labeled 10-nm gold nanoparticles with customizable surface functional groups for endothelial targeting and drug delivery applications. The approach supports mechanistic de-risking in cardiovascular research by probing glycocalyx integrity and nanoparticle uptake under diseased versus healthy endothelial conditions. The platform provides a scalable, reproducible foundation for lead identification and preclinical validation of nanotherapeutic candidates.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of endothelial permeability and glycocalyx function as therapeutic targets in cardiovascular disease models.
- Operational Value: Provides a tunable nanoparticle scaffold for functional group screening to optimize target binding and reduce off-target effects.
Screening & Assay Development
- Scientific Value: Generates standardized, fluorescently detectable nanoparticles for quantitative uptake assays in endothelial cell models.
- Operational Value: Supports high-confidence screening through reproducible size control (10.5 nm hydrodynamic diameter) and surface chemistry control via PEG thiol exchange.
Translational & Preclinical Research
- Scientific Value: Facilitates translation from in vitro endothelial uptake to in vivo biodistribution studies via biocompatible PEG coating and fluorescence tracking.
- Operational Value: Enables risk-adjusted advancement by correlating glycocalyx degradation with enhanced nanoparticle uptake as a biomarker of endothelial dysfunction.
Pipeline & Workflow Integration
The method fits within the discovery-to-preclinical continuum, supporting early target validation through endothelial interaction assays and enabling lead optimization via surface functionalization for improved delivery precision.
- Discovery Biology: Supports hypothesis testing on endothelial barrier function and target accessibility in disease-relevant models.
- Screening: Delivers assay-ready nanoparticles with consistent size and fluorescence for reliable compound or ligand screening campaigns.
- Analytics: Provides quantitative hydrodynamic size (DLS), fluorescence emission profiles, and cellular uptake metrics for data-driven decision making.
- Translational Research: Connects endothelial glycocalyx probing to preclinical continuity through visualization of nanoparticle localization in vasculature.
- Enterprise Reuse: Establishes a modular nanoparticle platform adaptable across multiple targets and therapeutic indications via surface chemistry modification.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence in target validation by enabling direct visualization of nanoparticle-endothelium interactions.
- Operational Value: Ensures reproducibility through standardized dialysis, lyophilization, and fluorescence conjugation protocols.
- Strategic Value: Improves go/no-go decisions by linking nanoparticle uptake to glycocalyx integrity as a disease-relevant readout.
- Portfolio Impact: Supports risk-adjusted prioritization of nanotherapeutic candidates based on endothelial penetration and biocompatibility profiles.
Implementation Considerations
- Requires expertise in nanoparticle synthesis, PEGylation, and fluorescence labeling techniques.
- Dependent on access to dialysis equipment, lyophilizer, TEM, DLS, spectrofluorometer, and confocal microscopy.
- Necessitates cross-team standardization for consistent nanoparticle batch production and quality control.
- Adaptation considerations include varying PEG thiol types and fluorophore selection for different detection channels.
- Practical limitations include the need for light protection during fluorescence conjugation and potential aggregation if dialysis is incomplete.
Biopharma FAQs
Why does nanoparticle size matter for endothelial targeting?
The 10-nm hydrodynamic diameter allows nanoparticles to probe the endothelial glycocalyx without disrupting normal vasculature function, enabling assessment of endothelial permeability under diseased conditions.
How does PEGylation improve nanoparticle utility in drug delivery?
PEG coating increases hydrodynamic radius to 10.5 nm, provides biocompatibility, extends circulation time, and presents functional groups for further customization with targeting ligands or drugs.
What quantitative measurements enable assessment of nanoparticle uptake?
Fluorescence microscopy and confocal imaging quantify nanoparticle uptake by measuring red fluorescent signal intensity in endothelial cells, particularly in models with degraded glycocalyx.
Why are replication requirements important for nanoparticle characterization?
Replication across dialysis cycles and fluorescence conjugation steps ensures consistent size, surface functionality, and biocompatibility, which are critical for reliable endothelial interaction data.
What statistical analysis is needed before implementing this nanoparticle platform?
Comparative analysis of nanoparticle uptake between healthy and diseased endothelial models, supported by viability assays and fluorescence quantification, is required to validate target engagement and selectivity.
Chapters in this video
0:05
Title
0:38
Synthesis of Polyethylene Glycol-coated Gold Nanoparticles (PEG-AuNPs)
3:13
Conjugation of Fluorophores onto the PEG-AuNP NH2 Groups
4:56
Characterization of Fluorescent PEG-AuNPs
8:46
Results: Size and Biocompatibility of THPC-coated and Fluorescent PEG-AuNPs
10:19
Conclusion
